Literature DB >> 16365797

Orbital pseudotumor as an initial manifestation of multicentric Castleman's disease.

Masaru Inatani1, Satoshi Kashii1, Kazumasa Nosaka2, Nobuyoshi Arima2.   

Abstract

BACKGROUND: To report on a patient with multicentric Castleman's disease (MCD) who showed an orbital pseudotumor as an initial manifestation. CASE: A Japanese male patient, 65 years old, initially exhibited swelling of the left eyelid. Computed tomography and magnetic resonance imaging showed an infiltrating orbital mass around the left eye. OBSERVATIONS: The patient was treated several times with short courses of oral corticosteroids without significant response. Eight years after the first examination, he was referred to our neuroophthalmology clinic owing to persistent eyelid swelling. He exhibited an accelerated erythrosedimentation rate, polyclonal hypergammaglobulinemia, and multiple cervical and thoracic mediastinal lymphadenopathies. Histopathological examination revealed mixed-type MCD from a cervical lymph node and chronic inflammatory cell infiltration from eyelid swelling. Four months after his first visit, the patient's condition was complicated by fever, general fatigue, and hypoxemia. A cell marker study of the swollen lymph node showed monoclonality, indicating the development of non-Hodgkin's lymphoma.
CONCLUSIONS: The clinical course in this case suggests that an inflammatory reaction in the orbital tissue was initially present, before MCD, and that non-Hodgkin's lymphoma subsequently developed.

Entities:  

Mesh:

Year:  2005        PMID: 16365797     DOI: 10.1007/s10384-005-0252-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  12 in total

Review 1.  Castleman's disease.

Authors:  G Palestro; F Turrini; M Pagano; L Chiusa
Journal:  Adv Clin Path       Date:  1999 Jan-Apr

2.  Successful treatment of multicentric Castleman's disease with bilateral orbital tumour using rituximab.

Authors:  Makoto Ide; Eiichi Ogawa; Kanji Kasagi; Yasunori Kawachi; Tetsuro Ogino
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

3.  Ocular involvement in Castleman's disease. Response to radiotherapy.

Authors:  J W Gittinger
Journal:  Ophthalmology       Date:  1989-11       Impact factor: 12.079

4.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

5.  Interleukin-6 receptor expression in the peripheral B cells of patients with multicentric Castleman's disease.

Authors:  T Ishiyama; M Koike; S Nakamura; T Kakimoto; Y Akimoto; N Tsuruoka
Journal:  Ann Hematol       Date:  1996-10       Impact factor: 3.673

6.  Castleman disease presenting with ophthalmic signs and symptoms.

Authors:  T Kurokawa; S Suzuki; K Kawaguchi; N Fujisawa; N Yoshimura
Journal:  Am J Ophthalmol       Date:  1999-07       Impact factor: 5.258

Review 7.  Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review.

Authors:  Claire Larroche; Patrice Cacoub; Jean Soulier; Eric Oksenhendler; Jean-Pierre Clauvel; Jean-Charles Piette; Martine Raphael
Journal:  Am J Hematol       Date:  2002-02       Impact factor: 10.047

8.  Orbital lymphomas and Castleman's disease.

Authors:  M P Snead; J N James; D R Snead; D K Robson; S N Rizk
Journal:  Eye (Lond)       Date:  1993       Impact factor: 3.775

9.  Castleman's disease in the orbit. A 20-year follow-up.

Authors:  Ghassan Ayish Alyahya; Jan Ulrik Prause; Steffen Heegaard
Journal:  Acta Ophthalmol Scand       Date:  2002-10

10.  Hyaline-vascular type Castleman's disease involving both orbits.

Authors:  Keun-Sung Park; You-Jin Choi; Kyu-Sang Song
Journal:  Acta Ophthalmol Scand       Date:  2002-10
View more
  3 in total

1.  Hypertensive choroidopathy in Castleman's disease.

Authors:  David T L Liu; Jerry A Shields; C L Li; H K Ng; Dennis S C Lam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-06-16       Impact factor: 3.117

2.  Clinical Analysis of Castleman's Disease of the Lacrimal Gland.

Authors:  Dongping Li; Dongrun Tang; Fengyuan Sun
Journal:  J Ophthalmol       Date:  2020-11-23       Impact factor: 1.909

3.  Retinal vein occlusion during flare of multicentric Castleman's disease.

Authors:  Igor Kozak; Erin G Reid
Journal:  Clin Ophthalmol       Date:  2013-08-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.